LightDark Log in Sign up

‹ Back to screener

LUPIN.NS Lupin Ltd.

Healthcare

Price history

1M 6M 1Y 3Y Max
2025-08-21 ₹1962.50
2026-08-21 ₹2192.70
Change over window +11.73%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 54.2%
Trailing 20-day average 58.6%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 348121 188808 54.24%
2026-08-27 964354 398017 41.27%
2026-08-26 1230081 742821 60.39%
2026-08-25 545272 302319 55.44%
2026-08-24 475169 285702 60.13%
2026-08-21 770287 482183 62.60%
2026-08-20 531963 299412 56.28%
2026-08-19 781480 529281 67.73%
2026-08-18 694324 450201 64.84%
2026-08-17 730234 426994 58.47%
2026-08-14 591412 338757 57.28%
2026-08-13 583016 356484 61.14%
2026-08-12 861217 515277 59.83%
2026-08-11 1304449 731431 56.07%
2026-08-10 3762236 1976588 52.54%
2026-08-07 2046981 859931 42.01%
2026-08-06 1185492 749232 63.20%
2026-08-05 1494574 1063793 71.18%
2026-08-04 1169093 755259 64.60%
2026-08-03 1717110 1094217 63.72%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers LUPIN.NS to fetch more history.

Insider trading activity

Disclosed Person Category Type Mode Quantity Value (₹) Resulting stake
09 Sep 2021 Dr. Kamal K Sharma Employees/Designated Employees Sell Market Sale 15000 14775000 0.03% XBRL
06 Sep 2021 MR. NEEL DESHBANDHU GUPTA Promoters Buy Gift 2650 0 0.01% XBRL
06 Sep 2021 Veda Nilesh Gupta Promoters Buy Gift 2650 0 0.02% XBRL
06 Sep 2021 MR. NILESH D. GUPTA Promoters Sell Gift 5300 0 0.20% XBRL
27 Aug 2021 MR. NILESH D. GUPTA Promoters Buy Market Purchase 5300 5000974 0.20% XBRL
18 Aug 2021 SUNIL MAKHARIA Employees/Designated Employees Sell Market Sale 20000 19480000 0.00% XBRL
16 Aug 2021 Ramesh Swaminathan Employees/Designated Employees Sell Market Sale 10000 9780000 0.00% XBRL
10 Jul 2021 Veda Nilesh Gupta Promoters Buy Gift 2140 0 0.01% XBRL
10 Jul 2021 MR. NILESH D. GUPTA Promoters Sell Gift 2140 0 0.20% XBRL
30 Jun 2021 SUNIL MAKHARIA Employees/Designated Employees Sell Market Sale 2000 2322000 0.01% XBRL
30 Jun 2021 Naresh Kumar Gupta Employees/Designated Employees Sell Market Sale 3000 3489150 0.01% XBRL
30 Jun 2021 Debabrata Chakravorty Employees/Designated Employees Sell Market Sale 3000 3474910 0.00% XBRL
29 Jun 2021 MR. NILESH D. GUPTA Promoters Buy Market Purchase 2140 2483660 0.20% XBRL
28 Jun 2021 Dr. Kamal K Sharma Employees/Designated Employees Buy ESOP 50000 20786500 0.04% XBRL
28 Jun 2021 Dr. Rajender Kumar Kamboj Employees/Designated Employees Buy ESOP 20000 14024000 0.02% XBRL
24 Jun 2021 Ms. Minaxi Bhatt Employees/Designated Employees Sell Market Sale 1000 1126651 0.00% XBRL
23 Jun 2021 Naresh Kumar Gupta Employees/Designated Employees Sell Market Sale 500 575075 0.01% XBRL
23 Jun 2021 Jon Stelzmiller Employees/Designated Employees Sell Market Sale 1225 1375837 0.00% XBRL
18 Jun 2021 Naresh Kumar Gupta Employees/Designated Employees Sell Market Sale 500 588905 0.01% XBRL
17 Jun 2021 Ms. Minaxi Bhatt Employees/Designated Employees Sell Market Sale 1255 1446317 0.00% XBRL

SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers LUPIN.NS to fetch more.

Ratios as of FY2025-26 (Annual) · Price ₹2201.80 INR (live) · fetched 2026-08-23 23:36 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score

Ratios

P/E
18.88
P/E = Price / EPS
Source trace
P/E = Price / (ProfitOrLossAttributableToOwnersOfParent / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹2,201.80 / (₹53,328,400,000 / 457,200,000 shares) = ₹2,201.80 / ₹116.64 EPS
FY2025-26 · Annual filing
ROE
23.76%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitOrLossAttributableToOwnersOfParent / EquityAttributableToOwnersOfParent → ₹53,328,400,000 / ₹224,482,700,000 = 23.76%
FY2025-26 · Annual filing
Debt/Equity
0.26
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹59,102,000,000 / ₹224,482,700,000 = 0.26
FY2025-26 · Annual filing
Current Ratio
1.90
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹240,273,800,000 / ₹126,512,400,000 = 1.90
FY2025-26 · Annual filing
ROCE
27.73%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹78,649,500,000 / (₹224,482,700,000 + ₹59,102,000,000) = 27.73%
FY2025-26 · Annual filing
Dividend Yield
0.54%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹5,483,400,000 / 457,200,000 shares) / ₹2,201.80 = ₹11.99 / ₹2,201.80
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, 3.0y actual) 18.9%
Net Profit (3y) 131.4%
Revenue (5y, 3.0y actual) 18.9%
Net Profit (5y) 131.4%
Revenue (10y, 3.0y actual) 18.9%
Net Profit (10y) 131.4%

Operating Margin Trend

Expanding

FY2022-23 6.0%
FY2023-24 13.7%
FY2024-25 19.0%
FY2025-26 28.1%

ROCE Trajectory

FY2022-23 5.9%
FY2023-24 16.0%
FY2024-25 19.3%
FY2025-26 27.7%

Earnings Quality

No persistent gap detected

Net Profit CAGR 131.41% vs CFO CAGR 57.41% over 3.0y (2023-03-31 → 2026-03-31); most recent year: Net Profit +62.51% vs CFO +1655.04%

Sector-Relative Percentile (Healthcare)

ROE 96th
ROCE 87th
Debt/Equity 33th
P/E 93th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q4 FY2023-24 Q1 FY2024-25 Q2 FY2024-25 Q3 FY2024-25 Q4 FY2024-25 Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q4 FY2025-26 Q1 FY2026-27 Source
Revenue ₹4,960.79 Cr. ₹5,600.33 Cr. ₹5,672.73 Cr. ₹5,767.71 Cr. ₹5,667.13 Cr. ₹6,268.34 Cr. ₹7,047.51 Cr. ₹7,167.52 Cr. ₹7,474.66 Cr. ₹8,276.89 Cr. Gross ₹8,276.89 Cr. RevenueFromOperations
Net Profit ₹359.43 Cr. incl. minority ₹368.22 Cr. ₹801.31 Cr. incl. minority ₹805.54 Cr. ₹852.63 Cr. incl. minority ₹859.48 Cr. ₹855.16 Cr. incl. minority ₹858.86 Cr. ₹772.52 Cr. incl. minority ₹782.38 Cr. ₹1,219.03 Cr. incl. minority ₹1,221.46 Cr. ₹1,477.92 Cr. incl. minority ₹1,484.83 Cr. ₹1,175.55 Cr. incl. minority ₹1,180.51 Cr. ₹1,460.34 Cr. incl. minority ₹1,468.67 Cr. ₹1,415.00 Cr. incl. minority ₹1,416.98 Cr. ProfitOrLossAttributableToOwnersOfParent

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers LUPIN.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitOrLossAttributableToOwnersOfParent53328400000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital457200000.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets240273800000.0
CurrentLiabilities126512400000.0
EquityAttributableToOwnersOfParent224482700000.0
BorrowingsCurrent + BorrowingsNoncurrent59102000000.0

My notes